# TVM Capital: portfolio, investments and team

> TVM Capital is a private equity based in Germany. 81 investments on record, latest Apr 2024. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/tvm-capital-life-science (Millionrounds; every figure on the page links to its filing or article)

Germany · [Investor](https://millionrounds.com/investors)

# TVM Capital

Last cheque observed Apr 2024. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet Private equity

Seed Series A Series B Psychedelics Gene Therapy Therapeutic

Follow TVM Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Ftvm-capital-life-science)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 81 on record

Since the last cheque **944** days **00** hrs **00** min **00** sec

Median round **$25M** Rounds led **1 of 81** Sole investor **5 rounds** Exits **13 from the portfolio** Mostly in **United States, 53%**

Pitch TVM Capital

## TVM Capital highlights

- 01 81 rounds on record
- 02 Mostly Venture and Series B: 53% of its rounds
- 03 Sole investor in 5 rounds, median $1.6M
- 04 13 exits from the portfolio

## What they do

> TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe. From their own website

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Psychedelics Gene Therapy Therapeutic
- **Based in:** Munich, Germany
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **81 appearances**

- **2024** 1 round
- **Apr** **[Smart Reporting](https://millionrounds.com/company/smart-reporting)** Series C · DE · Firms' own news pages **$25M** *Led*
- **2015** 4 rounds
- **Jul** **[leon nanodrugs](https://millionrounds.com/company/leon-nanodrugs)** Series A · DE **$20M** With 4 others
- **Apr** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Series C · US **$25M** With 5 others
- **Apr** **[Esperas Pharma](https://millionrounds.com/company/esperas-pharma)** **Undisclosed** With 1 other
- **Jan** **[CoLucid Pharmaceuticals](https://millionrounds.com/company/colucid-pharmaceuticals)** Series C · US **$37M** With 7 others
- **2014** 5 rounds
- **Aug** **[FAAH Pharma](https://millionrounds.com/company/faah-pharma)** **Undisclosed** Sole investor
- **Jun** **[Definiens](https://millionrounds.com/company/definiens)** Venture · DE **$20M** With 2 others
- **May** **[Proteon Therapeutics](https://millionrounds.com/company/proteon-therapeutics)** Series D · US **$45M** With 9 others
- **Apr** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Venture · US **$6.0M** With 4 others
- **Mar** **[invendo medical](https://millionrounds.com/company/invendo-medical)** Venture · US **$28M** With 3 others
- **2013** 3 rounds
- **Aug** **[Ixchelsis](https://millionrounds.com/company/ixchelsis)** Growth · GB · finsmes.com **Undisclosed** Sole investor
- **Jun** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Series B · US · finsmes.com **$33M** With 4 others
- **Jan** **[Kaneq Bioscience](https://millionrounds.com/company/kaneq-bioscience)** CA · marketwatch.com **Undisclosed** Sole investor
- **2012** 4 rounds
- **Oct** **[Definiens](https://millionrounds.com/company/definiens)** Venture · DE · finsmes.com **$13M** With 1 other
- **Jul** **[bluebird bio](https://millionrounds.com/company/bluebird-bio)** Series D · US · in.finance.yahoo.com **$60M** With 6 others
- **Apr** **[Argos Therapeutics](https://millionrounds.com/company/argos-therapeutics)** Series D · US · argostherapeutics.com **$25M** With 4 others
- **Jan** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Venture · DE · finsmes.com **$19M** With 5 others
- **2011** 2 rounds
- **Apr** **[bluebird bio](https://millionrounds.com/company/bluebird-bio)** Venture · US · live-pr.com **$30M** With 4 others
- **Apr** **[F-star Biotechnology Limited](https://millionrounds.com/company/f-star-biotechnology-limited)** Venture · AT · f-star.com **$22M** With 6 others
- **2010** 7 rounds
- **Dec** **[Cambridge Broadband Networks](https://millionrounds.com/company/cambridge-broadband-networks)** Venture · GB · finsmes.com **$17M** With 4 others
- **Aug** **[Anchor Therapeutics](https://millionrounds.com/company/anchor-therapeutics)** Series B · US · anchortx.com **$10M** With 2 others
- **Jul** **[Cerenis Therapeutics](https://millionrounds.com/company/cerenis-therapeutics)** Series C · FR · cerenis.com **$52M** With 6 others
- **Apr** **[DIREVO Industrial Biotechnology](https://millionrounds.com/company/direvo-industrial-biotechnology)** Series D · DE · onbiovc.com **$8.1M** With 1 other
- **Mar** **[VPIsystems](https://millionrounds.com/company/vpisystems)** Venture · US **$4.0M** With 4 others
- **Mar** **[bluebird bio](https://millionrounds.com/company/bluebird-bio)** Series B · US · fiercebiotech.com **$35M** With 4 others
- **Feb** **[DIREVO Industrial Biotechnology](https://millionrounds.com/company/direvo-industrial-biotechnology)** Venture · DE · direvo.com **$8.3M** With 1 other
- **2009** 6 rounds
- **Nov** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Series B · DE · probiodrug.de **$54M** With 7 others
- **Aug** **[Ubidyne](https://millionrounds.com/company/ubidyne)** Series B · US · freshnews.com **$43M** With 3 others
- **Aug** **[Rapid Micro Biosystems](https://millionrounds.com/company/rapid-micro-biosystems)** Series A · US · onbiovc.com **$19M** With 3 others
- **May** **[Proteon Therapeutics](https://millionrounds.com/company/proteon-therapeutics)** Series B · US · proteontherapeutics.com **$50M** With 7 others
- **Feb** **[Cambridge Broadband Networks](https://millionrounds.com/company/cambridge-broadband-networks)** Venture · GB · totaltele.com **$7.5M** With 3 others
- **Jan** **[Revolt Technology](https://millionrounds.com/company/revolt-technology)** Series B · US **$13M** With 6 others
- **2008** 12 rounds
- **Dec** **[Extend Media](https://millionrounds.com/company/extend-media)** Series C · US · newteevee.com **$10M** With 2 others
- **Oct** **[Silicon Hive](https://millionrounds.com/company/silicon-hive)** Venture · NL · eetimes.com **$7.0M** With 2 others
- **Sept** **[CommProve](https://millionrounds.com/company/commprove)** Venture · IE · commprove.com **$14M** With 2 others
- **Aug** **[SpePharm](https://millionrounds.com/company/spepharm)** Venture · NL · spepharm.com **$39M** With 2 others
- **Aug** **[BitWave](https://millionrounds.com/company/bitwave)** Series B · US · marketwatch.com **$10M** With 2 others
- **May** **[Arteris](https://millionrounds.com/company/arteris)** Series C · US · venturebeat.com **$7.5M** With 4 others
- **May** **[Winbox Technologies](https://millionrounds.com/company/winbox-technologies)** Series A · DE · eetimes.com **$1.6M** Sole investor
- **Apr** **[Concert Pharmaceuticals](https://millionrounds.com/company/concert-pharmaceuticals)** Series C · US **$37M** With 11 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **9** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **13 in all**

**[Definiens](https://millionrounds.com/company/definiens)** Bought by MedImmune **$150M** Nov 2014

**[bluebird bio](https://millionrounds.com/company/bluebird-bio)** Listed **$101M** Jun 2013

**[Intercell](https://millionrounds.com/company/intercell)** Bought by Vivalis **Undisclosed** Dec 2012

**[Netviewer](https://millionrounds.com/company/netviewer)** Bought by Citrix Online **Undisclosed** Dec 2010

**[Extend Media](https://millionrounds.com/company/extend-media)** Bought by [Cisco](https://millionrounds.com/fund/cisco) **$80M** Aug 2010

**[CoreOptics](https://millionrounds.com/company/coreoptics)** Bought by [Cisco](https://millionrounds.com/fund/cisco) **$99M** May 2010

**[VPIsystems](https://millionrounds.com/company/vpisystems)** Bought by Elanti Systems **Undisclosed** Mar 2010

**[DIREVO Industrial Biotechnology](https://millionrounds.com/company/direvo-industrial-biotechnology)** Bought by Bayer HealthCare **$297M** Sept 2008

**[Jerini](https://millionrounds.com/company/jerini)** Bought by [Shire](https://millionrounds.com/fund/shire) **$554M** Jul 2008

**[Sirtris Pharmaceuticals](https://millionrounds.com/company/sirtris-pharmaceuticals)** Bought by [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) **$720M** Apr 2008

**[Arrow Therapeutics](https://millionrounds.com/company/arrow-therapeutics)** Bought by [AstraZeneca](https://millionrounds.com/fund/astrazeneca) **Undisclosed** Feb 2007

**[TissueInformatics](https://millionrounds.com/company/tissueinformatics)** Bought by BioImagine **Undisclosed** Jun 2006

**[TissueInformatics](https://millionrounds.com/company/tissueinformatics)** Bought by Icoria **Undisclosed** Mar 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$25M** the round, not its cheque Alone, median **$1.6M**

Led 1 of 81 rounds **1%**

- **Sole investor:** 5 rounds
- **Last cheque:** Apr 2024
- **Exits:** 13 from the portfolio

Rounds by stage said on their site

- Venture *21*
- Series B said *19*
- Series C *16*
- Series A said *13*
- Series D *6*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Dec 2023 Nov 2026

Often in the room with

- [Skyline Ventures](https://millionrounds.com/fund/skyline-ventures) 8
- [Accel](https://millionrounds.com/fund/accel) 6
- [Atlas Venture](https://millionrounds.com/fund/atlas-venture) 6
- [3i Group](https://millionrounds.com/fund/3i-group) 5
- [Amadeus Capital Partners](https://millionrounds.com/fund/amadeus-capital-partners) 4
- [Crescendo Ventures](https://millionrounds.com/fund/crescendo-ventures) 4

**Pitching TVM Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as TVM Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Skyline Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/skyline-ventures)[**Accel** VC firm **6** rounds together](https://millionrounds.com/fund/accel)[**Atlas Venture** VC firm **6** rounds together](https://millionrounds.com/fund/atlas-venture)[**3i Group** Private equity **5** rounds together](https://millionrounds.com/fund/3i-group)[**Amadeus Capital Partners** VC firm **4** rounds together](https://millionrounds.com/fund/amadeus-capital-partners)[**Crescendo Ventures** Growth equity **4** rounds together](https://millionrounds.com/fund/crescendo-ventures)[**Easton Capital** VC firm **4** rounds together](https://millionrounds.com/fund/easton-capital-investment-group)[**Forbion Capital Partners** Private equity **4** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Gimv** Private equity **4** rounds together](https://millionrounds.com/fund/gimv)[**Intersouth Partners** VC firm **4** rounds together](https://millionrounds.com/fund/intersouth-partners)[**Kleiner Perkins Caufield & Byers** VC firm **4** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Quaker Partners** VC firm **4** rounds together](https://millionrounds.com/fund/quaker-partners)

## Recently backed

The latest companies TVM Capital put money into.

[**Smart Reporting** $25M · Apr 2024](https://millionrounds.com/company/smart-reporting)

## Quick answers about TVM Capital

### What does TVM Capital invest in?

TVM Capital invests most often at Venture and Series B (53% of the rounds on record), in sectors such as Psychedelics, Gene Therapy and Therapeutic.

### How active is TVM Capital?

81 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Apr 2024.

### What has TVM Capital invested in recently?

Its most recent investments on record: Smart Reporting (Series C, Apr 2024).

### How big are TVM Capital's cheques?

The median round it joins is $25M.

### Does TVM Capital lead rounds?

Sometimes: it led 1 of its 81 investments on record (1%).

### Where does TVM Capital invest?

Most of the companies it backs are in the United States (53%), Germany (24%) and the United Kingdom (8%).

### Is TVM Capital investing now?

No investments in the last 12 months; the latest was in Apr 2024.

### Who does TVM Capital invest alongside?

Most often Skyline Ventures (8 rounds together), Accel (6 rounds together) and Atlas Venture (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=tvm-capital-life-science) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=tvm-capital-life-science)